By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Medical Diagnostics and V&F Analyse- und Messtechnik announced Monday that they have formed an alliance based on mass spectrometry technology.

Unde the terms of the alliance, Oxford, UK-based OMD will offer and support V&F's high-performance mass spec analyzers in the UK and Ireland. In addition, OMD will establish a contract batch sample analysis service at its Oxford labs to provide analytical services to customers using V&F's instruments.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Jun
20
Sponsored by
PerkinElmer

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.